SOURCES SOUGHT
A -- Medication Discovery Using Rat Relapse Models
- Notice Date
- 12/6/2013
- Notice Type
- Sources Sought
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- HHS-NIH-NIDA-SBSS-14-013
- Archive Date
- 1/5/2014
- Point of Contact
- Jeff Schmidt, Phone: (301) 443-6677, Brian H O'Laughlin, Phone: (301) 443-6677
- E-Mail Address
-
schmidtjr@mail.nih.gov, olaughlinb@mail.nih.gov
(schmidtjr@mail.nih.gov, olaughlinb@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a SMALL BUSINESS SOURCES SOUGHT NOTICE to determine the availability of small businesses (e.g., 8(a), veteran-owned small businesses, services-disabled veteran owned small businesses, HUB Zone small businesses, small disadvantaged businesses, and women-owned small businesses) having in-house capability to develop methodologies and to perform in vivo rodent behavioral pharmacology for other drug dependence disorders, using drug self-administration reinstatement models. The objects of this contract are to determine the in vivo efficacy of novel compounds in animal models of relapse. This includes the following tests in animals trained to self-administer cocaine: (1) the ability of test compound to block footshock or other stress-induced reinstatement of responding after a period of experimental extinction; (2) the ability of a test compound to block cocaine-priming-induced reinstatement of responding after a period of extinction; and (3) the ability of a test compound to block the effects of a conditioned cue (previously paired with cocaine) to reinstate responding for cocaine after a period of extinction. Due to the nature of the compounds which will be evaluated under this contract, it is mandatory that offerors possess a DEA Research Registration for Schedules II to V in order to handle substances under the Controlled Substances Act of 1970. In addition, the successful offeror must either possess, or demonstrate the ability to obtain a DEA registration for Schedule I controlled substances. The established NAICS code is 541712. Information sent should be relevant and specific in the technical area under consideration, on each of the following qualifications: (1) extensive experience and competence in the field of drug abuse; (2) scientific experience conducting rodent behavioral pharmacology studies; and (3) demonstrated compliance with NIH guidelines on the care and use of laboratory animals. Interested organizations must demonstrate and document, in any capability statements submitted, extensive experience with and the ability to perform the above tasks. Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. Documentation may include, but not limited to, contracts both Government and commercial the organization performed, references, i.e. names, title, telephone numbers and any other information serving to document the organizations capability (e.g., awards, commendations, etc.). THIS IS NOT A REQUEST FOR PROPOSALS: This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent for the Government's use. Any proprietary information should be so marked. All capability statements must provide the following: (1) company name and address; (2) point of contact; (3) phone/fax/email; (4) NAICS Code(s); (5) business size and status; (6) capability information in response to the requirement and qualifications identified in this notice; and (7) type of small business your organization classifies itself as (i.e.: women-owned, HUBZONE, etc.). Written capability statements must be SUBMITTED NO LATER THAN DECEMBER 21, 2013 to the above Contracting Office Address, Attn: Jeff Schmidt. Electronic capability statements will be accepted by the primary point of contact.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-SBSS-14-013/listing.html)
- Record
- SN03247513-W 20131208/131206234330-6e02cc286f9bad187b650cf67fdd22af (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |